METROPOLITAN LIFE INSURANCE CO/NY - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 145 filers reported holding AMNEAL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$29,034
+63.2%
6,880
+19.9%
0.00%
+100.0%
Q2 2023$17,785
+123.0%
5,7370.0%0.00%
Q1 2023$7,974
-36.3%
5,737
-8.8%
0.00%
-100.0%
Q4 2022$12,519
-1.5%
6,2910.0%0.00%0.0%
Q3 2022$12,708
+34.1%
6,291
+111.1%
0.00%
Q2 2022$9,476
-64.2%
2,980
-53.1%
0.00%
-100.0%
Q1 2022$26,475
-72.5%
6,349
-68.4%
0.00%0.0%
Q4 2021$96,332
-26.5%
20,111
-18.1%
0.00%
-50.0%
Q3 2021$131,145
-24.7%
24,559
-27.8%
0.00%0.0%
Q2 2021$174,054
-9.7%
33,995
+18.7%
0.00%
-33.3%
Q1 2021$192,707
+52.1%
28,634
+3.3%
0.00%
+50.0%
Q4 2020$126,694
+3.7%
27,723
-12.0%
0.00%0.0%
Q3 2020$122,228
-30.8%
31,502
-15.1%
0.00%
-33.3%
Q2 2020$176,577
+32.2%
37,096
-3.4%
0.00%0.0%
Q1 2020$133,569
-29.9%
38,382
-2.9%
0.00%0.0%
Q4 2019$190,511
+237.6%
39,525
+103.1%
0.00%
+200.0%
Q3 2019$56,431
-72.5%
19,459
-32.0%
0.00%
-66.7%
Q2 2019$205,256
-49.4%
28,6270.0%0.00%
-57.1%
Q1 2019$405,645
+4.7%
28,6270.0%0.01%
-12.5%
Q4 2018$387,323
-39.0%
28,6270.0%0.01%
-27.3%
Q3 2018$635,23328,6270.01%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$90,819,89014.58%
Eversept Partners, LP 2,644,988$11,161,8490.94%
TPG GP A, LLC 12,328,767$52,027,3970.90%
Nantahala Capital Management 2,212,757$9,337,8350.80%
Rubric Capital Management LP 4,024,500$16,983,3900.64%
Hedges Asset Management LLC 84,600$357,0120.31%
Signature Wealth Management Partners, LLC 66,666$281,3310.28%
Tejara Capital Ltd 96,672$407,9560.23%
Tranquilli Financial Advisor LLC 71,414$301,3670.22%
EAM Investors, LLC 230,271$971,7440.19%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders